WHO ICTRP trial
Effect of metformin combined with radiotherapy on radiosensitivity of CD44+CD24…
ChiCTR1900023063 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900023063 |
|---|---|
| Public title | Effect of metformin combined with radiotherapy on radiosensitivity of CD44+CD24- MCF-7 cells in breast cancer |
| Scientific title | Effect of metformin combined with radiotherapy on radiosensitivity of CD44+CD24- MCF-7 cells in breast cancer |
| Primary sponsor | Affiliated Hospital of Guizhou Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | breast cancer |
| Interventions | 1:use metformin;2:radiotherapy;3:metformin and radiotherapy;4:none |
| Registration date | May 9, 2019 |
| Target size | 1:5;2:5;3:5;4:5 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: